Zentalis Pharmaceuticals, Inc. Share Price
Stocks
ZNTL
US98943L1070
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 09/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.800 USD | -5.71% |
|
+0.80% | +181.48% |
| 08-20 | Zentalis Pharmaceuticals Insider Bought Shares Worth $15,172,500, According to a Recent SEC Filing | MT |
| 08-17 | Zentalis Pharmaceuticals Closes Offering of Common Shares | MT |
| Market Cap | 360M 310M 291M 266M 497M 34.23B 499M 3.45B 1.34B 17.44B 1.35B 1.32B 55.25B | P/E 2026 * |
-1.74x | P/E 2027 * | -1.96x |
|---|---|---|---|---|---|
| Enterprise Value | 155M 134M 126M 115M 214M 14.77B 215M 1.49B 576M 7.52B 583M 570M 23.84B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 13.5x |
| Free-Float |
78.24% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ZNTL | Delayed | |
CBOE
| ZNTL | Real-time |
Last Transcript : Zentalis Pharmaceuticals, Inc.
| 1 day | -5.71% | ||
| 1 week | +0.80% | ||
| Current month | +1.06% | ||
| 1 month | -9.95% | ||
| 3 months | +6.15% | ||
| 6 months | +53.23% | ||
| Current year | +181.48% |
| 1 week | 3.79 |  | 4.19 |
| 1 month | 3.49 | | 4.42 |
| Current year | 1.32 | | 6.95 |
| 1 year | 1.21 | | 6.95 |
| 3 years | 1.01 | | 25.33 |
| 5 years | 1.01 | | 87.19 |
| 10 years | 1.01 | | 87.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 62 | 12/11/2024 |
| Director of Finance/CFO | - | 12/11/2024 | |
Ingmar Bruns
CTO | Chief Tech/Sci/R&D Officer | 51 | 12/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
David Johnson
CHM | Chairman | 61 | 15/05/2022 |
Enoch Kariuki
BRD | Director/Board Member | 44 | 08/02/2021 |
Jan Skvarka
BRD | Director/Board Member | 59 | 11/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/08/26 | Buy | 4,335,000 | 4.5791% | |||
| 26/05/26 | Free | Director | 114,200 | 0.1604% | ||
| 06/02/26 | Sell | Chief Technology Officer | 3,297 | 0.0046% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.71% | +0.80% | +137.50% | -84.97% | 360M | |
| -0.94% | -0.71% | +45.60% | +103.25% | 68.52B | |
| -0.74% | -5.87% | +30.95% | +74.66% | 62.88B | |
| +3.13% | +1.71% | -12.50% | +390.48% | 28.13B | |
| -2.74% | -6.31% | +26.33% | +11.24% | 25.56B | |
| -0.54% | -5.47% | -3.88% | -18.31% | 24.65B | |
| -1.69% | -4.28% | +18.88% | -18.87% | 19.81B | |
| -4.27% | +3.07% | +211.22% | +362.48% | 17.69B | |
| -1.37% | -4.51% | -5.21% | +507.43% | 14.66B | |
| +1.14% | -0.34% | +52.38% | +163.82% | 14.45B | |
| Average | -1.37% | -1.38% | +50.13% | +149.12% | 27.67B | |
| Weighted average by Cap. | -0.80% | -1.86% | +36.64% | +138.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 16.38M 14.09M 13.27M 12.09M 22.62M 1.56B 22.71M 157M 60.79M 794M 61.5M 60.16M 2.52B |
| Net income | -165M -142M -133M -122M -227M -15.66B -228M -1.58B -611M -7.98B -618M -605M -25.28B | -169M -145M -137M -125M -233M -16.07B -234M -1.62B -627M -8.19B -634M -621M -25.94B |
| Net Debt | -205M -176M -166M -151M -283M -19.46B -284M -1.96B -759M -9.92B -768M -751M -31.41B | -139M -120M -113M -103M -193M -13.27B -193M -1.34B -518M -6.76B -524M -512M -21.42B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | US$3.800 | -5.71% | 782,547 |
| 08/09/26 | US$4.030 | +1.00% | 519,171 |
| 04/09/26 | US$3.990 | -2.92% | 1,000,321 |
| 03/09/26 | US$4.110 | +9.02% | 1,366,548 |
| 02/09/26 | US$3.770 | +1.62% | 897,801 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZNTL Stock
Select your edition
All financial news and data tailored to specific country editions
